Company Long-Term Loans and Borrowings: Cassava (SAVA)

Brandmark of Cassava (SAVA)

Massive investments in simufilam development and strict FDA oversight create significant barriers to entry for new players. The price action of Cassava Sciences, Inc. (SAVA) reflects long-term debt, which stands at 0.00. Market potential is immense due to the global shortage of dementia therapies, although success depends on the regulator's verdict. The Cassava Sciences, Inc. (SAVA) team brings together leading experts working without bureaucracy to create a breakthrough medical product.

Cassava Sciences (SAVA) Company Long-Term Debts: for the period 07/04/2022 - 03/11/2026

Summary analytical data breakdowns for Cassava (SAVA)

- market price and analyst price targets:
Stock Price cassavasciences.com|SAVA - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Cassava Sciences|SAVA - Total Company Value
- book capitalization information:
Net Asset Value per Share Cassava Sciences|SAVA - Book Capitalization|Market Cap to Net Assets Ratio cassavasciences.com|SAVA - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Cassava Sciences, Inc.|SAVA - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Cassava Pharma|SAVA - Company Debts|Debts to Net Assets Cassava Sciences|SAVA - Company Long-Term Debts|Company Short-Term Debts Cassava Sciences|Quick Liquidity cassavasciences.com
- earnings and market multiples details:
SAVA - Net Profit
Analysis of all company metrics:SAVA cassavasciences.com
Original product of Cassava Sciences, Inc.

The growth of long-term liabilities exceeding one year signals a risk of cash flow gaps and an increased debt burden, making the issuer's long-term liability statistics a critical indicator of solvency. For Cassava Sciences, Inc. (SAVA) during the period of reputation under Richard Berry's management, any sharp spike on this chart could indicate excessive borrowing, heightening investor caution ahead of the publication of final clinical trial results.

Who Cassava Sciences, Inc. competes with

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Liabilities vikingtherapeutics.com (VKTX)|Company Long-Term Debts SUPN|Company Long-Term Debts Catalyst Pharma (CPRX)|Company Long-Term Debt Denali Therapeutics Inc DNLI|Long-Term Debt Volume Harmony Corp (HRMY)|BHVN - Company Long-Term Debt|Long-Term Debt Volume amylyx.com AMLX|TRVI: Company Long-Term Debts|Praxis Precision Medicines Inc (PRAX) - Company Long-Term Debts|Company Long-Term Liabilities AVXL|Company Long-Term Debt CBLL|Company Long-Term Debts PRTA|Company Long-Term Debts alector.com (ALEC)|Annexon - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings OMER|NGNE - Company Long-Term Debt|Long-Term Debt Volume AC Immune Inc ACIU|VYGR: Company Long-Term Debts|Company Long-Term Liabilities neumoratx.com|SCLX (Scilex) - Company Long-Term Debts|Tevogen Bio Holdings Inc. (TVGN) - Long-Term Debt Volume|Company Long-Term Debts ACOG|CGTX - Long-Term Debt|Company Long-Term Debt Inhibikase Therapeutics IKT|ASRT: Company Long-Term Indebtedness|Coya - Company Long-Term Debts|Vistagen Therapeutics (VTGN) - Company Long-Term Liabilities|OVID: Company Long-Term Debts|Long-Term Debt Acumen Pharmaceuticals, Inc (ABOS)|Company Long-Term Debt CervoMed Inc.|Alterity Therapeutics Ltd (ATHE) - Long-Term Debt Volume|Company Long-Term Liabilities CLNN (Clene Inc.)|PEPG (pepgen.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts JUNS (Jupiter Neurosciences Inc)|Long-Term Debt Volume Relmada Corp (RLMD)|ANVS - Company Long-Term Debt|GRCE (Grace Therapeutics, Inc.) - Company Long-Term Indebtedness|AIFF: Company Long-Term Debts|Company Long-Term Liabilities Klotho Neurosciences|Company Long-Term Liabilities NRSN|Reviva Pharmaceuticals, Inc. (RVPH) - Long-Term Debt Volume|Company Long-Term Debt MetaVia Inc (MTVA)|Long-Term Debt Volume neuraxis.com|Company Long-Term Debts HSDT (Helius Medical Technologies)|Company Long-Term Debts Passage Bio Inc. PASG|NEUP: Company Long-Term Liabilities|NERV: Company Long-Term Debt|ATHA: Company Long-Term Debts|addextherapeutics.com (ADXN) - Company Long-Term Debts|Company Long-Term Debt Alzamend Neuro Inc.|Company Long-Term Indebtedness CYCN (Cyclerion)|Company Long-Term Debts PTIX|KTTA - Long-Term Debt|Cortigent - Company Long-Term Liabilities|Company Long-Term Debts avenuetx.com ATXI|BCLI - Company Long-Term Debt|Company Long-Term Loans and Borrowings CARA (Cara Therapeutics Inc.)|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Long-Term Debt Eliem Therapeutics Inc. (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Company Long-Term Debts|Company Long-Term Liabilities longboardpharma.com (LBPH)|Company Long-Term Debts MRNS|Company Long-Term Debts NKGen Biotech Inc (NKGN)|Company Long-Term Debt NeuroBo NRBO|Long-Term Debt Volume Sage Therapeutics Inc (SAGE)|SNPX - Company Long-Term Debt|Long-Term Debt Volume trevena.com TRVN|VIGL: Company Long-Term Debts|Anew Medical Inc. (WENA) - Company Long-Term Debts|Company Long-Term Liabilities CERE